Chromosome 21 and Down syndrome: from genomics to pathophysiology
- 1 October 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Genetics
- Vol. 5 (10), 725-738
- https://doi.org/10.1038/nrg1448
Abstract
The sequence of chromosome 21 was a turning point for the understanding of Down syndrome. Comparative genomics is beginning to identify the functional components of the chromosome and that in turn will set the stage for the functional characterization of the sequences. Animal models combined with genome-wide analytical methods have proved indispensable for unravelling the mysteries of gene dosage imbalanceKeywords
This publication has 87 references indexed in Scilit:
- Chromosome aberrations in solid tumorsNature Genetics, 2003
- A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactylyHuman Molecular Genetics, 2003
- A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24.Human Molecular Genetics, 2003
- MOLECULARMECHANISMS FORGENOMICDISORDERSAnnual Review of Genomics and Human Genetics, 2002
- Recent Segmental Duplications in the Human GenomeScience, 2002
- Assembly of microarrays for genome-wide measurement of DNA copy numberNature Genetics, 2001
- Impaired Differentiation of Schwann Cells in Transgenic Mice with IncreasedPMP22Gene DosageJournal of Neuroscience, 1996
- Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher diseaseNature Genetics, 1994
- Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosageNeuron, 1994
- Charcot–Marie–Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unitNature Genetics, 1992